These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 1320799)

  • 21. Amino acid substitutions in leucine zipper motif in the F-specific domain of human parainfluenza virus 3 HN protein play important roles in the protein function.
    Zhang W; Ren G; Wu B; Liu X; Wang G; Song Y; Xu H; Wen H; Wang Z
    Intervirology; 2008; 51(5):311-21. PubMed ID: 19018146
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional chimeric HN glycoproteins derived from Newcastle disease virus and human parainfluenza virus-3.
    Deng R; Mirza AM; Mahon PJ; Iorio RM
    Arch Virol Suppl; 1997; 13():115-30. PubMed ID: 9413532
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The DI-DII linker of human parainfluenza virus type 3 fusion protein is critical for the virus.
    Liu Y; Chi M; Wen H; Zhao L; Song Y; Liu N; Chi L; Wang Z
    Virus Genes; 2020 Feb; 56(1):37-48. PubMed ID: 31768710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibiting Human Parainfluenza Virus Infection by Preactivating the Cell Entry Mechanism.
    Bottom-Tanzer SF; Rybkina K; Bell JN; Alabi CA; Mathieu C; Lu M; Biswas S; Vasquez M; Porotto M; Melero JA; Más V; Moscona A
    mBio; 2019 Feb; 10(1):. PubMed ID: 30782664
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The aberrant gene-end transcription signal of the matrix M gene of human parainfluenza virus type 3 downregulates fusion F protein expression and the F-specific antibody response in vivo.
    Lingemann M; Surman S; Amaro-Carambot E; Schaap-Nutt A; Collins PL; Munir S
    J Virol; 2015 Mar; 89(6):3318-31. PubMed ID: 25589643
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Replacement of the ectodomains of the hemagglutinin-neuraminidase and fusion glycoproteins of recombinant parainfluenza virus type 3 (PIV3) with their counterparts from PIV2 yields attenuated PIV2 vaccine candidates.
    Tao T; Skiadopoulos MH; Davoodi F; Riggs JM; Collins PL; Murphy BR
    J Virol; 2000 Jul; 74(14):6448-58. PubMed ID: 10864657
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chimeric bovine respiratory syncytial virus with attachment and fusion glycoproteins replaced by bovine parainfluenza virus type 3 hemagglutinin-neuraminidase and fusion proteins.
    Stope MB; Karger A; Schmidt U; Buchholz UJ
    J Virol; 2001 Oct; 75(19):9367-77. PubMed ID: 11533200
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regions on the hemagglutinin-neuraminidase proteins of human parainfluenza virus type-1 and Sendai virus important for membrane fusion.
    Bousse T; Takimoto T; Gorman WL; Takahashi T; Portner A
    Virology; 1994 Nov; 204(2):506-14. PubMed ID: 7941317
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Down-regulation of paramyxovirus hemagglutinin-neuraminidase glycoprotein surface expression by a mutant fusion protein containing a retention signal for the endoplasmic reticulum.
    Tanaka Y; Heminway BR; Galinski MS
    J Virol; 1996 Aug; 70(8):5005-15. PubMed ID: 8764007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of the human parainfluenza virus 3 attachment protein's neuraminidase activity on its capacity to activate the fusion protein.
    Porotto M; Murrell M; Greengard O; Doctor L; Moscona A
    J Virol; 2005 Feb; 79(4):2383-92. PubMed ID: 15681439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional interaction of paramyxovirus glycoproteins: identification of a domain in Sendai virus HN which promotes cell fusion.
    Tanabayashi K; Compans RW
    J Virol; 1996 Sep; 70(9):6112-8. PubMed ID: 8709235
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Virion-Associated Cholesterol Regulates the Infection of Human Parainfluenza Virus Type 3.
    Tang Q; Liu P; Chen M; Qin Y
    Viruses; 2019 May; 11(5):. PubMed ID: 31096557
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Electron tomography imaging of surface glycoproteins on human parainfluenza virus 3: association of receptor binding and fusion proteins before receptor engagement.
    Gui L; Jurgens EM; Ebner JL; Porotto M; Moscona A; Lee KK
    mBio; 2015 Feb; 6(1):e02393-14. PubMed ID: 25691596
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic analysis of human parainfluenza virus type 3 obtained in Croatia, 2011-2015.
    Košutić-Gulija T; Slovic A; Ljubin-Sternak S; Mlinarić-Galinović G; Forčić D
    J Med Microbiol; 2017 Apr; 66(4):502-510. PubMed ID: 28463659
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of a quantitative fusion assay to evaluate HN-receptor interaction for human parainfluenza virus type 3.
    Levin Perlman S; Jordan M; Brossmer R; Greengard O; Moscona A
    Virology; 1999 Dec; 265(1):57-65. PubMed ID: 10603317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of parainfluenza virus type 3 and Newcastle disease virus hemagglutinin-neuraminidase receptor binding: effect of receptor avidity and steric hindrance at the inhibitor binding sites.
    Porotto M; Murrell M; Greengard O; Lawrence MC; McKimm-Breschkin JL; Moscona A
    J Virol; 2004 Dec; 78(24):13911-9. PubMed ID: 15564499
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of antigen insertion site and vector dose on immunogenicity and protective capacity in Sendai virus-based human parainfluenza virus type 3 vaccines.
    Mason JN; Elbahesh H; Russell CJ
    J Virol; 2013 May; 87(10):5959-69. PubMed ID: 23514887
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Packaging and Prefusion Stabilization Separately and Additively Increase the Quantity and Quality of Respiratory Syncytial Virus (RSV)-Neutralizing Antibodies Induced by an RSV Fusion Protein Expressed by a Parainfluenza Virus Vector.
    Liang B; Ngwuta JO; Herbert R; Swerczek J; Dorward DW; Amaro-Carambot E; Mackow N; Kabatova B; Lingemann M; Surman S; Yang L; Chen M; Moin SM; Kumar A; McLellan JS; Kwong PD; Graham BS; Schaap-Nutt A; Collins PL; Munir S
    J Virol; 2016 Nov; 90(21):10022-10038. PubMed ID: 27581977
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Syncytium formation by recombinant vaccinia viruses carrying bovine parainfluenza 3 virus envelope protein genes.
    Sakai Y; Shibuta H
    J Virol; 1989 Sep; 63(9):3661-8. PubMed ID: 2547990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaccination with a human parainfluenza virus type 3 chimeric FHN glycoprotein formulated with a combination adjuvant induces protective immunity.
    Garg R; Brownlie R; Latimer L; Gerdts V; Potter A; van Drunen Littel-van den Hurk S
    Vaccine; 2017 Dec; 35(51):7139-7146. PubMed ID: 29153777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.